Monoclonal Antibody-Based Sequential Therapy for Deep Remission in Multiple Myeloma
Clinical trial NCT03224507 · COMPLETED
Trial details
- NCT number
- NCT03224507
- Sponsor
- University of Alabama at Birmingham
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-03-14
- Primary completion
- 2023-05-01
- Enrollment
- 123
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.